Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $11.3M, listed on NASDAQ, employing roughly 10 people, carrying a beta of -1.09 to the broader market. Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. Led by Yong Qi Quek, public since 2025-04-10.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for CUPR as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.